Skip to main content

Find Clinical Trials

Home
Conditions
Laryngeal Neoplasms

Clinical trial condition

Laryngeal Neoplasms

Explore clinical trials studying Laryngeal Neoplasms. Study availability and eligibility vary by location and protocol.

180 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Laryngeal Neoplasms trial results

Recruiting

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

NCT01473784

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +70 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Recruiting

CONFIRM: Magnetic Resonance Guided Radiation Therapy

NCT04368702

Conditions: Bladder Cancer, Breast Carcinoma In Situ, Breast Diseases, +44 more
Locations: Brigham & Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer

NCT07391345

Conditions: Glottic Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases, +8 more
Locations: Lithuanian University of Health Sciences Kaunas Clinics Kaunas, Lithuania

View Trial Details

Recruiting

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

NCT05793151

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +22 more
Locations: Washington University in St. Louis St Louis, Missouri, United States

Duke University Medical Center Durham, North Carolina, United States

Medical University of South Carolina Charleston, South Carolina, United States

Baylor College of Medicine Houston, Texas, United States

View Trial Details

Recruiting

Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)

NCT04908696

Conditions: Glottic Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +16 more
Locations: Lei Tao Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

NCT06080503

Conditions: Head and Neck Neoplasms, Laryngeal Carcinoma, Laryngeal Diseases, +7 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

View all 16 locations

View Trial Details

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations: Massive Bio SYNERGY-AI site Birmingham, Alabama, United States

Massive Bio SYNERGY-AI site Mobile, Alabama, United States

Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States

Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Recruiting

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

NCT06914999

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +32 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

View Trial Details

Recruiting

VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer

NCT04057209

Conditions: Carcinoma, Carcinoma in Situ, Carcinoma, Squamous Cell, +14 more
Locations: Institut Gustave Roussy Paris, France

Tata Memorial Hospital Mumbai Mumbai, Maharashtra, India

Inselspital, Bern University Hospital Bern, Canton of Bern, Switzerland

University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details